X4 Pharmaceuticals, Inc.
DEUTERATED COMPOUNDS AND USES THEREOF

Last updated:

Abstract:

The present invention provides deuterium-enriched CXCR4 inhibitors, pharmaceutical compositions, and methods of using such deuterium-enriched CXCR4 inhibitors and pharmaceutical compositions to treat, prevent, or ameliorate a disease, disorder, or condition such as cancer or WHIM syndrome.

Status:
Application
Type:

Utility

Filling date:

15 Jul 2021

Issue date:

20 Jan 2022